David Dahlquist, a co-chair of Winston & Strawn’s healthcare and life sciences group who works on antitrust matters, is leaving the firm to become senior trial counsel in the U.S. Justice Department’s antitrust division.
Dahlquist’s last day at the firm is Friday, Winston disclosed in two filings made the same day in two different Chicago federal court cases on behalf of Evanston, Ill.-based NorthShore University HealthSystem.
Dahlquist confirmed his new position and declined to comment further. Winston chairman Tom Fitzgerald congratulated Dahlquist on his move in a statement Friday.
Winston said in one of Friday’s filings that although Dahlquist is withdrawing, the firm will continue to represent NorthShore in a 15-year-old class action lawsuit accusing it of having an illegal monopoly on healthcare services due to its ownership of three Chicago-area hospitals. NorthShore has denied the allegations.
The other Friday filing said Winston, along with Seyfarth Shaw, will also continue to represent NorthShore in a class action lawsuit filed by employees who accused the hospital system of discriminating against them by failing to grant them exemptions from its COVID-19 vaccine mandate.
NorthShore, which denies the allegations, struck a proposed $10.3 million settlement with the employees on Friday. The deal now requires the federal court’s approval.
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
CVS Health Explores Potential Breakup Amid Investor Pressure: Report
Oct 3, 2024 by
CPI
DirecTV Acquires Dish TV, Creating 20 Million-Subscriber Powerhouse
Oct 3, 2024 by
CPI
South Korea Fines Kakao Mobility $54.8 Million for Anti-Competitive Practices
Oct 3, 2024 by
CPI
Google Offers Settlement in India’s Antitrust Case Regarding Smart TVs
Oct 3, 2024 by
CPI
Attorney Challenges NCAA’s $2.78 Billion Settlement in Landmark Antitrust Cases
Oct 3, 2024 by
nhoch@pymnts.com
Antitrust Mix by CPI
Antitrust Chronicle® – Refusal to Deal
Sep 27, 2024 by
CPI
Antitrust’s Refusal-to-Deal Doctrine: The Emperor Has No Clothes
Sep 27, 2024 by
Erik Hovenkamp
Why All Antitrust Claims are Refusal to Deal Claims and What that Means for Policy
Sep 27, 2024 by
Ramsi Woodcock
The Aspen Misadventure
Sep 27, 2024 by
Roger Blair & Holly P. Stidham
Refusal to Deal in Antitrust Law: Evolving Jurisprudence and Business Justifications in the Align Technology Case
Sep 27, 2024 by
Timothy Hsieh